In Alzheimer’s disease (AD), NPTX2 mRNA and protein levels are reduced in the postmortem neocortex compared to cognitively normal, age-matched controls [3]. This evidence concerns the gene NPTX2 and early-onset autosomal dominant Alzheimer disease.